cs.AISep 4, 2026

A Hybrid Predictive Ensemble of Machine Learning and Deep Neural Networks for Early Cardiovascular Disease Risk Assessment

Authors: Balaji Venkateswaran

Organizations: Independent Researcher, Chennai, India

Abstract

This study introduces an intelligent framework that integrates machine learning and deep neural network ensemble techniques for early detection and prognosis of cardiovascular diseases. The system utilizes real-time physiological data collected from Internet of Medical Things (IoMT) devices, including ECG sensors, heart rate monitors, and blood pressure trackers. To ensure the accuracy and reliability of input data, preprocessing steps such as noise reduction, normalization, and missing value imputation are employed. The most significant health indicators are identified through effective feature selection methods and then processed using optimized classifiers such as Support Vector Machines (SVM), Random Forests, and eXtreme Gradient Boosting (XGBoost), which are combined in an ensemble architecture to improve diagnostic precision. The framework demonstrates remarkable performance in predicting cardiovascular disease risk, achieving higher accuracy, reduced false positives, and enhanced consistency compared to conventional methods. It is designed on a cloud-based infrastructure that ensures scalability and real-time processing for continuous patient monitoring. Experimental evaluation on real-world cardiovascular datasets confirms the framework's efficiency in early-stage risk assessment and clinical decision support. The results highlight the potential of combining traditional machine learning and deep learning paradigms to achieve proactive healthcare management and improve patient outcomes.

Figures & tables

Explore similar work

Aug 19, 2026

Transforming Heart Disease Prediction with Advanced Machine Learning Techniques

Heart disease remains the leading cause of mortality globally, necessitating early and accurate detection to improve patient outcomes. This research focuses on the predictive analysis of heart disease using machine learning (ML) techniques, comparing the performance of multiple classifiers to identify the most accurate and least error-prone method. Two datasets from UCI and Kaggle repositories were utilized, each containing 14 attributes related to heart health indicators. Techniques including J48, Naive Bayes, Logistic Regression, Simple Cart, Bagging, Decision Stump, AdaBoost, Artificial Neural Networks, and Support Vector Machine (SVM) were applied. Evaluation metrics such as Mean Absolute Error (MAE), Relative Absolute Error (RAE), accuracy, precision, recall, and F-measure were used for performance comparison. Results revealed that SVM achieved the highest performance on the UCI dataset, while Simple Cart performed best on the Kaggle dataset, offering the highest accuracy and lowest error rates. The research work concludes that ML models, when properly tuned and validated, can significantly assist in the early diagnosis of heart disease, offering critical support for clinical decision-making. Future work may involve hybrid approaches and the use of more recent datasets to further improve prediction accuracy.
Feb 25, 2026

Integrating Machine Learning Ensembles and Large Language Models for Heart Disease Prediction Using Voting Fusion

Cardiovascular disease is the primary cause of death globally, necessitating early identification, precise risk classification, and dependable decision-support technologies. The advent of large language models (LLMs) provides new zero-shot and few-shot reasoning capabilities, even though machine learning (ML) algorithms, especially ensemble approaches like Random Forest, XGBoost, LightGBM, and CatBoost, are excellent at modeling complex, non-linear patient data and routinely beat logistic regression. This research predicts cardiovascular disease using a merged dataset of 1,190 patient records, comparing traditional machine learning models (95.78% accuracy, ROC-AUC 0.96) with open-source large language models via OpenRouter APIs. Finally, a hybrid fusion of the ML ensemble and LLM reasoning under Gemini 2.5 Flash achieved the best results (96.62% accuracy, 0.97 AUC), showing that LLMs (78.9 % accuracy) work best when combined with ML models rather than used alone. Results show that ML ensembles achieved the highest performance (95.78% accuracy, ROC-AUC 0.96), while LLMs performed moderately in zero-shot (78.9%) and slightly better in few-shot (72.6%) settings. The proposed hybrid method enhanced the strength in uncertain situations, illustrating that ensemble ML is considered the best structured tabular prediction case, but it can be integrated with hybrid ML-LLM systems to provide a minor increase and open the way to more reliable clinical decision-support tools.
Mar 6, 2026

Enhancing the Detection of Coronary Artery Disease Using Machine Learning

Coronary Artery Disease (CAD) remains a leading cause of morbidity and mortality worldwide. Early detection is critical to recover patient outcomes and decrease healthcare costs. In recent years, machine learning (ML) advancements have shown significant potential in enhancing the accuracy of CAD diagnosis. This study investigates the application of ML algorithms to improve the detection of CAD by analyzing patient data, including clinical features, imaging, and biomarker profiles. Bi-directional Long Short-Term Memory (Bi-LSTM), Gated Recurrent Units (GRU), and a hybrid of Bi-LSTM+GRU were trained on large datasets to predict the presence of CAD. Results demonstrated that these ML models outperformed traditional diagnostic methods in sensitivity and specificity, offering a robust tool for clinicians to make more informed decisions. The experimental results show that the hybrid model achieved an accuracy of 97.07%. By integrating advanced data preprocessing techniques and feature selection, this study ensures optimal learning and model performance, setting a benchmark for the application of ML in CAD diagnosis. The integration of ML into CAD detection presents a promising avenue for personalized healthcare and could play a pivotal role in the future of cardiovascular disease management.